Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    RGX-104
Previous Study | Return to List | Next Study

A Study of RGX-104 in Patients With Advanced Solid Malignancies and Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02922764
Recruitment Status : Recruiting
First Posted : October 4, 2016
Last Update Posted : February 5, 2021
Sponsor:
Information provided by (Responsible Party):
Rgenix, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : March 2022